L. Boucai, M. Zafereo, M. Cabanillas, Thyroid cancer: a review. JAMA 331, 425–435 (2024)
Article CAS PubMed Google Scholar
D. Chen, B. Lang, D. McLeod, K. Newbold, M. Haymart, Thyroid cancer. Lancet 401, 1531–1544 (2023)
M. Schlumberger, S. Leboulleux, Current practice in patients with differentiated thyroid cancer. Nat. Rev. Endocrinol. 17, 176–188 (2021)
Article CAS PubMed Google Scholar
P. Santhanam, P.W. Ladenson, Surveillance for differentiated thyroid cancer recurrence. Endocrinol. Metab. Clin. North Am. 48, 239–252 (2019)
N. Rajan, T. Khanal, M.D. Ringel, Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications. Endocrine 70, 24–35 (2020)
Article CAS PubMed Google Scholar
L. Zhang, Q. Feng, J. Wang, Z. Tan, Q. Li, M. Ge, Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities. Biochimica et. Biophysica Acta Rev. Cancer 1878, 188928 (2023)
Y. Zhang, Z. Xing, T. Liu, M. Tang, L. Mi, J. Zhu, W. Wu, T. Wei, Targeted therapy and drug resistance in thyroid cancer. Eur. J. Med. Chem. 238, 114500 (2022)
Article CAS PubMed Google Scholar
E. Birney, Mendelian randomization. Csh Perspect. Med 12, a41302 (2021)
G.D. Smith, D.A. Lawlor, R. Harbord, N. Timpson, I. Day, S. Ebrahim, Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 4, e352 (2007)
A.F. McRae, R.E. Marioni, S. Shah, J. Yang, J.E. Powell, S.E. Harris, J. Gibson, A.K. Henders, L. Bowdler, J.N. Painter et al. Identification of 55,000 replicated DNA methylation QTL. Sci. Rep. Uk 8, 17605 (2018)
U. Võsa, A. Claringbould, H. Westra, M.J. Bonder, P. Deelen, B. Zeng, H. Kirsten, A. Saha, R. Kreuzhuber, S. Yazar et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300–1310 (2021)
B.B. Sun, J. Chiou, M. Traylor, C. Benner, Y. Hsu, T.G. Richardson, P. Surendran, A. Mahajan, C. Robins, S.G. Vasquez-Grinnell et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329–338 (2023)
Article CAS PubMed Google Scholar
M.I. Kurki, J. Karjalainen, P. Palta, T.P. Sipilä, K. Kristiansson, K.M. Donner, M.P. Reeve, H. Laivuori, M. Aavikko, M.A. Kaunisto et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518 (2023)
Article CAS PubMed Google Scholar
L. Jiang, Z. Zheng, H. Fang, J. Yang, A generalized linear mixed model association tool for biobank-scale data. Nat. Genet 53, 1616–1621 (2021)
Article CAS PubMed Google Scholar
C. Finan, A. Gaulton, F. Kruger, R. Lumbers, T. Shah, J. Engmann, L. Galver, R. Kelley, A. Karlsson, R. Santos et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med. 9, g1166 (2017)
R. Insolera, W. Shao, R. Airik, F. Hildebrandt, S.H. Shi, SDCCAG8 regulates pericentriolar material recruitment and neuronal migration in the developing cortex. Neuron 83, 805–822 (2014)
Article CAS PubMed Google Scholar
E.A. Otto, T.W. Hurd, R. Airik, M. Chaki, W. Zhou, C. Stoetzel, S.B. Patil, S. Levy, A.K. Ghosh, C.A. Murga-Zamalloa et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat. Genet 42, 840–850 (2010)
Article CAS PubMed Google Scholar
E. Schaefer, A. Zaloszyc, J. Lauer, M. Durand, F. Stutzmann, Y. Perdomo-Trujillo, C. Redin, V. Bennouna Greene, A. Toutain, L. Perrin et al. Mutations in SDCCAG8/NPHP10 cause bardet-biedl syndrome and are associated with penetrant renal disease and absent polydactyly. Mol. Syndromol. 1, 273–281 (2011)
Article CAS PubMed Google Scholar
R. Airik, G.G. Slaats, Z. Guo, A.C. Weiss, N. Khan, A. Ghosh, T.W. Hurd, S. Bekker-Jensen, J.M. Schroder, S.J. Elledge et al. Renal-retinal ciliopathy gene Sdccag8 regulates DNA damage response signaling. J. Am. Soc. Nephrol. 25, 2573–2583 (2014)
Article CAS PubMed Google Scholar
Y. Liu, Y. Geng, K. Li, F. Wang, H. Zhou, W. Wang, J. Hou, W. Liu, Comparative proteomic analysis of the function and network mechanisms of MASPIN in human lung cells. Exp. Ther. Med. 3, 470–474 (2012)
Article CAS PubMed Google Scholar
M.J. Scanlan, Y.T. Chen, B. Williamson, A.O. Gure, E. Stockert, J.D. Gordan, O. Tureci, U. Sahin, M. Pfreundschuh, L.J. Old, Characterization of human colon cancer antigens recognized by autologous antibodies. Int J. Cancer 76, 652–658 (1998)
Article CAS PubMed Google Scholar
J. Huang, E.H. Ji, X. Zhao, L. Cui, K. Misuno, M. Guo, Z. Huang, X. Chen, S. Hu, Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. J. Exp. Clin. Cancer Res. 38, 138 (2019)
Article CAS PubMed Google Scholar
T. Kawano, S. Yanoma, Y. Nakamura, O. Shiono, T. Kokatu, A. Kubota, M. Furukawa, M. Tsukuda, Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer. Am. J. Otolaryngol. 26, 308–313 (2005)
Article CAS PubMed Google Scholar
P. Wang, C. Weng, Y. Hou, S. Jian, K. Fang, M. Hou, K. Cheng, Activation of VCAM-1 and Its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Int J. Mol. Sci. 15, 3560–3579 (2014)
Article CAS PubMed Google Scholar
F. Zhou, J. Chen, G. Tao, M. Zhu, W. Xie, X. Cao, Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer. Resp. Med 108, 1670–1676 (2014)
Y.B. Ding, G.Y. Chen, J.G. Xia, X.W. Zang, H.Y. Yang, L. Yang, Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J. Gastroenterol. 9, 1409–1414 (2003)
Article CAS PubMed Google Scholar
Ö. Kemik, A.S. Kemik, I. Hasirci, M. Adaş, S. Purisa, A.C. Dülger, Serum level of soluble vascular adhesion molecule 1 in patients with rectal cancer. Eur. J. Gen. Med. 8, 105–109 (2011)
R.S. Svatek, C. Jeldres, P.I. Karakiewicz, N. Suardi, J. Walz, C.G. Roehrborn, F. Montorsi, K.M. Slawin, S.F. Shariat, Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence. Prostate 69, 886–894 (2009)
Article CAS PubMed Google Scholar
V. Dymicka-Piekarska, K. Guzinska-Ustymowicz, A. Kuklinski, H. Kemona, Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients. Thromb. Res. 129, e47–e50 (2012)
Article CAS PubMed Google Scholar
A.A. Tempia-Caliera, L.Z. Horvath, A. Zimmermann, T.T. Tihanyi, M. Korc, H. Friess, M.W. Büchler, Adhesion molecules in human pancreatic cancer. J. Surg. Oncol. 79, 93–100 (2002)
Article CAS PubMed Google Scholar
J.M. Scalici, S. Thomas, C. Harrer, T.A. Raines, J. Curran, K.A. Atkins, M.R. Conaway, L. Duska, K.A. Kelly, J.K. Slack-Davis, Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer. J. Nucl. Med. 54, 1883–1889 (2013)
Article CAS PubMed Google Scholar
F. Perabo, S. Sharma, R. Gierer, A. Wirger, R. Fimmers, G. Steiner, M. Adam, W. Schultze-Seemann, Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies. Indian J. Cancer 38, 1–7 (2001)
留言 (0)